Go to Market
Faster & More Reliably
Next Breath, a specialty company of Aptar Pharma, provides comprehensive solutions for the product development process from CMC support to finished batch release and post approval stability to regulatory agencies worldwide.
Our Industry Expertise
Next Breath uses the latest instrumentation and methodologies to provide our customers with the highest quality of analytical analysis of nasal drug products.
Next Breath inhalation testing services cover the entire product development process from CMC support to finished batch release and post approval stability for submission to regulatory agencies worldwide.
Next Breath scientists utilize the latest instrumentation and methodologies to provide customers with the highest quality of analytical analysis of extractables & leachables.
Next Breath has a wealth of regulatory experience with a proven track record of working with regulatory agencies across the globe.
Qualifications & Instrumentation
Next Breath’s world-leading scientists provide bespoke services using the latest instrumentation to you for the next phase of the drug development journey.
Next Breath is built on a solid foundation of mutual respect and trust. We approach everything we do with a collaborative spirit and ‘can do’ energy.
Our Industry Expertise
Next Breath specializes in analytical testing of drug delivery systems for inhalation and nasal products, extractables and leachables.
From Next Breath’s full-service cGMP-compliant laboratory, we provide bespoke pharma solutions across the entire product development process from CMC testing to finished batch release and post-approval stability. By approaching each step along the way with a regulatory mindset, we use our expertise and deep experience with agencies around the world to de-risk the development process.
Latest News & Events
2022 R&D Conference | San Francisco, CA
The 4th international conference on PharmScience Research & Development. Next Breath will be attending.
Next Breath Announces Injectable Extractable and Leachable Services
Baltimore, Maryland – January 19, 2018. Next Breath, a division of AptarGroup, Inc., is pleased to announce the extension of their cGMP analytical services to include development services for injectable delivery systems, with a core focus on extractables and leachables.
Brazilian National Sanitary Surveillance Agency (ANVISA) Certifies Next Breath as a Center for In Vitro Pharmaceutical Equivalence
Baltimore, USA – March 28th, 2014 – Next Breath is pleased to announce that the Brazilian National Sanitary Surveillance Agency